Maria Charlotte Fribert
Chief Executive Officer at TOLERANZIA AB
Maria Charlotte Fribert active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TOLERANZIA AB | Chief Executive Officer | 2016-04-10 | - |
| Investor Relations Contact | 2016-04-10 | - | |
| Chief Operating Officer | - | 2016-04-10 |
Career history of Maria Charlotte Fribert
Former positions of Maria Charlotte Fribert
| Companies | Position | Start | End |
|---|---|---|---|
Epixis SA
 Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Founder | - | - |
| AstraZeneca R&D Mölndal | Corporate Officer/Principal | - | - |
Training of Maria Charlotte Fribert
Statistics
International
| Sweden | 3 |
| France | 3 |
Operational
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Investor Relations Contact | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Private companies | 3 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
| AstraZeneca R&D Mölndal | |
Epixis SA
Epixis SA BiotechnologyHealth Technology Epixis SA is a biotechnology company that develops platform for preventive and therapeutic vaccines based on VLPs ('virus-like particles'). It manufactures seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as Human papillomavirus (HPV) or Human immunodeficiency virus (HIV). The company was incorporated in 2003 and is headquartered in Paris, Frace. | Health Technology |
